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PlexinD1 and Semaphorin Signaling Are Required
in Endothelial Cells for Cardiovascular Development
man et al., 1999). Semaphorins are expressed in the
central nervous system, where function has been exten-
sively analyzed (Luo et al., 1995). However, semaphorins
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University of Pennsylvania Health System phorins Sema4A and Sema4D function in specific im-
mune responses (Hall et al., 1996; Kumanogoh et al.,954 BRB II/III
421 Curie Boulevard 2002). Sema7A is expressed by lymphocytes and acti-
vates monocytes (Holmes et al., 2002). Sema3A isPhiladelphia, Pennsylvania 19104
expressed in the developing lung where it inhibits
branching morphogenesis (Ito et al., 2000).
Class 3 semaphorins (SEMA3 proteins) are secreted
Summary glycoproteins whose functions to guide axonal growth
cones have been well characterized. Sema3A functions
The identification of new signaling pathways critical as a potent axonal repellant and can repel axonal projec-
for cardiac morphogenesis will contribute to our un- tions from neurons of dorsal root ganglia (DRG) in vitro
derstanding of congenital heart disease (CHD), which (Luo et al., 1993; Messersmith et al., 1995; Puschel et
remains a leading cause of mortality in newborn chil- al., 1996; Varela-Echavarria et al., 1997). Mice with a
dren worldwide. Signals mediated by semaphorin li- targeted disruption of sema3A have severe axon guid-
gands and plexin receptors contribute to the intricate ance defects during early embryonic development (Be-
patterning of axons in the central nervous system. har et al., 1996; Taniguchi et al., 1997). Additional SEMA3
Here, we describe a related signaling pathway involv- proteins cause neuronal growth cone collapse in similar
ing secreted class 3 semaphorins, neuropilins, and a in vitro assays. Sema3F has recently been shown to play
plexin receptor, PlexinD1, expressed by endothelial a critical role in regulating peripheral nervous system
cells. Interruption of this pathway in mice results in connectivity (Sahay et al., 2003).
CHD and vascular patterning defects. The type of CHD Recently, receptors for some semaphorin ligands
caused by inactivation of PlexinD1 has previously been have been identified. In Drosophila, semaphorins di-
attributed to abnormalities of neural crest. Here, we rectly bind the transmembrane receptor plexin (Winberg
show that this form of CHD can be caused by cell- et al., 1998). Plexins are a large family of receptors that
autonomous endothelial defects. Thus, molecular are also conserved in vertebrates, and some vertebrate
programs that mediate axon guidance in the central semaphorin/plexin pairs have been identified. However,
nervous system also function in endothelial cells to SEMA3 proteins do not appear to bind plexin receptors
orchestrate critical aspects of cardiac morphogenesis. directly. Instead, they bind to receptors that include
members of the neuropilin family (Kolodkin et al., 1997).
Furthermore, the neuropilin receptor complex contains
Introduction a plexin subunit, which is thought to transduce intracel-
lular signals (He and Tessier-Lavigne, 1997; Rohm et al.,
Since the time of Vesalius, an association between the 2000; Takahashi et al., 1999). In vertebrates, there are
complex patterning of the vasculature and that of the two neuropilins and at least ten plexins. Hence, diverse
peripheral nervous system has been apparent to anato- cellular responses may be achieved by the large variety
mists. Nerves and blood vessels often course together, of potential ligand-receptor combinations (Raper, 2000;
and it has been proposed that axons provide guidance Takahashi et al., 1999; Tamagnone et al., 1999). In order
cues that pattern the vasculature (Mukouyama et al., to understand this diversity, it will be important to char-
2002). Alternatively, it is possible that blood vessels uti- acterize additional semaphorin-plexin and semaphorin-
lize parallel signaling pathways that result in predictable neuropilin/plexin interactions.
relationships between vascular and neural networks. In In the cardiovascular system, the analysis of neuropi-
the nervous system, axonal pathways are shaped by lins as semaphorin receptors is complicated by the fact
repulsive cues provided by ligands of the semaphorin that they also function as receptors for vascular endo-
family that are sensed by migrating neuronal growth
thelial growth factor (VEGF) (Soker et al., 1998). Neuropi-
cones through neuropilin and plexin receptors (Raper,
lin-1 (Npn-1) and Neuropilin-2 (Npn-2), in addition to
2000).
their ability to heterodimerize with plexins, can interact
Semaphorins represent a family of membrane bound
with the VEGF receptor KDR (kinase-insert domain-con-
and secreted factors characterized by a conserved sema-
taining receptor) on endothelial cells (ECs) and can bind
phorin domain (Kolodkin et al., 1993; Luo et al., 1993).
VEGF. Mouse knockouts of neuropilins have revealed
In vertebrates, there are 19 semaphorins divided into
essential roles for these receptors in vascular develop-five subclasses based on structural features and
ment (Takashima et al., 2002).whether they are membrane bound or secreted (Good-
Several lines of evidence suggest an important role
for semaphorins in the cardiovascular system. First, in
addition to severe nervous system defects, Sema3A-*Correspondence: epsteinj@mail.med.upenn.edu
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Figure 1. Endothelial-Specific Expression of plexinD1
(A) Whole-mount in situ hybridization of an E9.5 mouse embryo shows plexinD1 expression in the intersomitic blood vessels (arrow).
(B–H) Radioactive in situ hybridizations of sections of E9.5–E11.5 mouse embryos. (B–D) At E9.5, strong plexinD1 expression is seen in
intersomitic vessels (arrows, [B]), pharyngeal arch arteries (arrows, [C]), and outflow tract endothelium (arrows, [D]). At E10.5, plexinD1
expression is seen in endothelium lining the atria (at, [E]) and the dorsal aorta (ao, [F]). Notably, expression is seen in blood vessels surrounding
the dorsal root ganglia (drg, [F]) but not within the drg. (G) At E11.5, expression is seen in endothelium of the branchial arches (ba), heart (ht),
lining the dorsal aorta (ao), and other organs, as well as in a punctate pattern throughout the embryo where blood vessels are located. (H)
Endothelium lining the outflow tract (ot) of the heart expresses plexinD1, but not the mesenchyme of the endocardial cushions, populated at
this time point by neural crest cells.
(I and J) PlexinD1 protein is expressed in endothelial cells in a pattern similar to the pan-endothelial marker PECAM.
(K) Northern blot showing plexinD1 expression in cultured murine endothelial cell lines (1, Eoma; 2, MS-1; 3, MS-1/VEGF). Ethidium bromide
stained agarose gel shows 28S rRNA as loading control.
(L–R) Immunostaining confirms endothelial-specific PlexinD1 expression (L and N) that overlaps with that of von Willebrand factor (vWF, [M
and O]). PlexinD1 expression is non-overlapping with that of neurofilament indicated by staining with 2H3 antibody (P–R) even within the
region of the dorsal root ganglia (drg, high power shown in [R]).
PlexinD1 and Cardiovascular Development
109
Figure 2. Targeted Inactivation of plexinD1
(A) A targeting vector was constructed to replace the first coding exon of plexinD1, containing the sema domain, with a neomycin resis-
tance cassette.
(B) Southern blot of BamH1-digested genomic DNA isolated from ES cell clones, probed with a 5 probe demonstrates correct targeting of
the plexinD1 locus.
(C) PCR was used to genotype offspring from plexinD1/ intercrosses.
(D and E) plexinD1 transcripts are detected in wild-type (D) but not knockout (E) hearts of E11.5 embryos.
(F and G) PlexinD1 protein is also present in wild-type (F) but not knockout (G) E11.5 hearts.
(H–K) Cardiac expression of SEMA3 signaling components. (H) plexinD1 is expressed specifically in endothelium (white arrows), whereas
Npn-1 (I) and Npn-2 (J) are expressed in both myocardium (yellow arrows) and endothelium (white arrows). (K) sema3C expression is robust
in OT myocardium (yellow arrows).
deficient mice exhibit cardiovascular defects on some development have not been identified, though recent
evidence suggests that PlexinA1 may mediate signalinggenetic backgrounds (Behar et al., 1996). The cardiac
defects are characterized by right ventricular hypertro- by Sema6D during cardiac development (Toyofuku et
al., 2004). Here, we identify a plexin receptor that isphy and a dilated right atrium. sema3A/ embryos also
exhibit vascular defects (Serini et al., 2003). Second, essential for cardiac morphogenesis and determine the
cell type in which semaphorin signaling is required dur-Sema3C-deficient mice die in the perinatal period with
severe congenital cardiovascular defects (Feiner et al., ing heart development. Our results suggest that ECs
play an important role in orchestrating outflow tract sep-2001). These defects are reminiscent of those resulting
from ablation of cardiac neural crest cells in the chick. tation and morphogenesis, processes previously attrib-
uted primarily to neural crest. Finally, we propose aThird, an elegant mouse model by Gu and colleagues,
in which the ability of Npn-1 to transduce semaphorin model that integrates VEGF and semaphorin signaling
pathways in cardiovascular development.signals is disrupted, suggests that neuropilin-mediated
semaphorin signaling is required for cardiovascular pat-
terning (Gu et al., 2003). Thus, semaphorins and neuropi- Results and Discussion
lins function outside of the nervous system to regulate
cardiovascular development. Identification of plexinD1 and Generation
of plexinD1/ MiceSince neuropilins are expressed in both endothelium
and neural crest, it is not clear in which cell type neuropi- Using a bioinformatics approach, we identified a mouse-
expressed sequence tag (EST #AA138454) with homol-lin-mediated semaphorin signaling functions. Further-
more, plexin coreceptors required for cardiovascular ogy to members of the plexin family, to a human cDNA
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ascending aorta instead of from the coronary sinusTable 1. Genotypes of Offspring from plexinD1/ Intercrosses
(arrows, Figures 3C–3E). Increased vascularity is appar-
Age / / / # of Litters
ent on the surface of the ventricular chambers (Figure
E10.5 14 31 13 6 3B). Some null pups (5/26) display a right-sided aortic
E11.5 4 10 4 2 arch (Figure 3C). To better visualize vascular patterning,
E12.5 9 21 8 4
we performed polymer corrosion casts at E18.5 (FiguresE13.5-E16.5 14 30 22a 8
3D and 3E). In wild-type embryos, the pulmonary arteryP0 36 77 26b 17
and aorta are clearly distinct vessels, and the ductus3 weeks 32 66 0 14
arteriosus is patent. In plexinD1 knockout embryos, thea Three embryos were partially resorbed.
right and left pulmonary arteries arise from the truncusb All became cyanotic and died within 24 hr.
arteriosus, indicating a failure of OT septation. In some
cases (Figure 3E) the right subclavian artery arises from
a more cranial (distal) location than in wild-type, and
the left carotid artery is missing or atretic. The ductus(KIAA0620) and to a predicted human gene designated
arteriosus is absent, and the abnormal origin of the coro-PLEXIND1 (Tamagnone et al., 1999). Therefore, we des-
nary artery is apparent (arrow, Figure 3E). These cardio-ignated the mouse cDNA plexinD1. In situ hybridization
vascular defects are sufficient to account for perinatalanalysis indicates that plexinD1 is expressed by embry-
lethality of plexinD1-deficient mice. Thus, the cardiovas-onic vascular ECs. Between E9.5 and E11.5 (Figures
cular phenotype of plexinD1-deficient mice reveals an1A–1H), expression is robust in most, if not all, vascular
unexpected role for endothelium in OT morphogenesis.endothelium including endocardium, intersomitic ves-
sels, pulmonary vasculature, aorta, and pharyngeal arch
arteries. Notably, plexinD1 is not expressed in neural
Cardiac Neural Crest Migration Is Unaffected
crest-derived structures including the dorsal root gan-
in plexinD1/ Miceglia at these early time points (Figure 1F). Expression in
Failure of OT septation has been previously attributed
vascular endothelium persists throughout embryogene-
to defects in cardiac neural crest (Creazzo et al., 1998;
sis (data not shown). In the adult, plexinD1 is expressed
Kirby et al., 1983). To determine if loss of PlexinD1 af-
in heart, brain, lung, kidney, and testis (data not shown;
fected neural crest migration, we analyzed a set of mo-
van der Zwaag et al., 2002), consistent with broad ex-
lecular markers including endothelin receptor A (ednrA;
pression in the vasculature. Primary and immortalized
Figures 4A and 4B), FoxC1 (Figures 4C and 4D), and
EC lines including human umbilical vein endothelial cells
plexinA2 (Figures 4E and 4F). Neural crest cell migration
(HUVECs) also express plexinD1 (Figure 1K and data
appears normal in E12.5 plexinD1/ embryos. Neural
not shown). To detect protein expression, we generated
crest cells migrate properly to and surround the pharyn-
a polyclonal antibody against a portion of the extracellu-
geal arches and populate the endocardial cushions of
lar domain of PlexinD1. PlexinD1 is expressed in a pat-
the OT. In addition, patterning of the peripheral nervous
tern similar to the pan-endothelial cell marker PECAM
system appeared unaffected in E10.5 mutant embryos,
(platelet and endothelial cell adhesion molecule) (Fig-
as assessed by anti-neurofilament antibody staining
ures 1I and 1J). Finally, we performed double and triple-
(Figures 4G and 4H and data not shown).
immunostaining to verify endothelial-specific expres-
sion of PlexinD1 (Figures 1L–1R).
We generated mice with targeted inactivation of plexinD1 Pharyngeal Arch Patterning Defects and Failure
by homologous recombination in embryonic stem (ES) to Recruit Smooth Muscle in plexinD1/ Mice
cells (Figures 2A–2C). Inactivation of plexinD1 was con- Defects in cardiovascular development are evident as
firmed by both in situ hybridization (Figures 2D and 2E) early as E10.5. Normally, the 3rd, 4th, and 6th aortic arch
and immunohistochemistry (Figures 2F and 2G). We arteries can be easily identified within the segmented
were unable to detect either plexinD1 mRNA or PlexinD1 pharyngeal arches in frontal sections at this time point
protein in homozygous knockout embryos, suggesting (Figure 3F). In plexinD1 mutants, however, the 4th aortic
that we have generated a null allele. arch arteries are diminutive and the 6th aortic arch arter-
ies are extremely small or absent (Figure 3G). ECs are
present in the 3rd and 4th arch arteries of plexinD1-defi-
Congenital Heart Disease in plexinD1/ Mice cient embryos as determined by expression of PECAM
To determine if plexinD1 is required for survival, we (Figures 3H and 3I). Intriguingly, there is an excessive
analyzed offspring from intercrosses of heterozygous number of ECs in the vicinity of the 6th arch artery that
mice (Table 1). Most of the expected homozygous fail to coalesce into a vascular tube (Figures 3H and 3I).
knockout mice are born; however, all mutant pups be- The defective 6th arch artery explains the loss of ductus
come cyanotic shortly after birth and succumb within arteriosus in the newborn mutant mice, and the abnor-
24 hr. All newborn homozygotes that we examined (n  mal 4th arch artery is consistent with the incidence of
26) have structural cardiovascular defects involving the right-sided aortic arch that we observe. Deficient aortic
outflow tract (OT) of the heart and derivatives of the arch artery development could reflect a primary defect
aortic arch arteries. In each case, persistent truncus in endothelium that results in secondary failure to recruit
arteriosus (PTA) is present (Figures 3A–3C). The atria vascular smooth muscle, a process that is required for
are enlarged and thin-walled, and there is a uniform maintenance of aortic arch artery integrity (Kochilas et
abnormality characterized by an ectopic origin of a coro- al., 2002; Lindsay and Baldini, 2001). Consistent with this
hypothesis, there is a striking deficiency of differentiatednary artery which arises from the mid portion of the
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Figure 3. Congenital Heart Disease and Vascular Abnormalities in plexinD1/ Mice
(A) Two great vessels, aorta (Ao) and pulmonary artery (PA), arise from the wild-type P0 mouse heart.
(B) Only one great vessel, truncus arteriosus (TA), arises from plexinD1/ hearts at P0, and there is an abnormal origin of the coronary
artery (arrow).
(C) Some of the mutants also have a right-sided aortic arch and retro-esophageal right subclavian artery.
(D and E) Acrylic corrosion casts of P0 wild-type (D) and mutant (E) demonstrate a coronary artery anomaly in the mutants (arrows) and
truncus arteriosus.
(F and G) Frontal sections through the pharyngeal arch arteries (numbered) at E10.5 demonstrate that plexinD1/ embryos (G) have diminutive
4th pharyngeal arch arteries and are missing the 6th arch arteries compared to wild-type (F).
(H and I) PECAM staining confirms diminutive 4th arch arteries in mutant embryos (I) and excessive numbers of PECAM-expressing endothelial
cells in the vicinity of missing 6th arch arteries.
(J and K) Smooth muscle differentiation is defective in the 4th arch arteries of the mutants (K), compared to wild-type (J), as visualized by
SMA staining.
(L and M) By E12.5, the wild-type outflow tract (L) has septated into aorta (Ao) and pulmonary artery (PA), but septation does not occur in
the mutants (M), resulting in a persistent truncus arteriosus (TA), and the atria are enlarged.
(N and O) The myocardium is thinned in E12.5 mutants. There are also ectopic coronary vessels (arrows, [O]) on the epicardial surface of
mutant hearts.
(P and Q) Higher magnification of boxed regions shown in (N) and (O). Arrowheads (Q) show blood-filled vascular structures.
(R and S) PECAM whole-mount immunostaining labels well-organized intersomitic blood vessels of an E10.5 wild-type embryo (R), whereas
the intersomitic vessels of the mutant are disorganized (S).
(T and U) Intercostal blood vessels of plexinD1 mutant newborns (U) are also disorganized compared to wild-type (T).
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Figure 4. Preserved Cardiac Neural Crest Migration and Neuronal Patterning in plexinD1 Mutant Embryos
(A–F) Radioactive in situ hybridization of E12.5 wild-type (A, C, and E) or mutant (B, D, and F) embryos shows preserved expression of cardiac
neural crest markers ednrA (A and B), FoxC1 (C and D), and plexinA2 (E and F). Note comparable amounts of neural crest cells populating
the endocardial cushions of the outflow tract (arrows).
(G and H) Normal neuronal patterning, as visualized by immunostaining frontal sections of E10.5 wild-type (G) or mutant (H) embryos with
monoclonal antibody 2H3 directed against neurofilament.
smooth muscle cells expressing  smooth muscle actin is septated by E12.5 (Figure 3L), while there is no evi-
dence of conotruncal septation in null embryos (Figure(SMA) surrounding the 4th and 6th arch arteries of mutant
embryos compared to wild-type (Figures 3J and 3K). 3M). On the ventricular surface of mutant hearts, there
are an excessive number of small vessels (Figures 3OMutations in the endothelin pathway, by targeted dis-
ruption of endothelin-1 (ET-1), endothelin converting en- and 3Q) compared to wild-type (Figures 3N and 3P).
These vascular structures contain blood and expresszyme-1, or endothelin receptor A (ednrA), result in neural
crest-related defects involving the pharyngeal arch ar- PECAM, indicating that they are lined by endothelium
(data not shown).teries (Kurihara et al., 1995; Yanagisawa et al., 1998).
This pathway functions in pharyngeal arch endothelium Loss-of-function mutations in the zebrafish plexinD1
ortholog result in patterning defects of intersomiticand provides signals to surrounding mesenchyme, re-
sulting in proper remodeling of the great vessels. We blood vessels (Torres-Vazquez et al., 2004). In the
mouse, plexinD1 is strongly expressed by intersomiticdid not observe differences in ET-1 or ednrA expression
in plexinD1 mutant embryos (Supplemental Data [http:// vessels at E9.5 (Figure 1A). By E10.5, patterning of inter-
somitic vessels is clearly abnormal in plexinD1 knockoutwww.developmentalcell.com/cgi/content/7/1/107/
DC1] and Figures 4E and 4F). However, subtle defects embryos, as evidenced by whole-mount PECAM immu-
nostaining (Figures 3R and 3S). The vessels of mutantin endothelin expression or protein processing remain
possible and future work will be required to address embryos are disorganized and are not confined to re-
gions between somites. Analogous defects in the inter-these possibilities and to examine potential genetic in-
teractions between these signaling pathways. costal blood vessels of newborn plexinD1 knockout
mice are also present (Figures 3T and 3U). These defectsWe examined the expression of a series of genes
previously implicated in endothelial cell signaling and are less severe than those seen in embryos, suggesting
a partial recovery of intersomitic vessel development ataortic arch artery patterning (Abramsson et al., 2003;
Hellstrom et al., 1999; Kuo et al., 1997; Shin et al., 2001; later stages. Furthermore, we do not observe changes
in cell death or proliferation in mutant embryos, as deter-Yanagisawa et al., 1998). endothelin-1, ephrinB2, PDGF-b,
PDGFR-, and LKLF were expressed in the OT and pha- mined by TUNEL and phospho-histone H3 staining, re-
spectively (data not shown). These results, coupled withryngeal arch artery endothelium at comparable levels in
both wild-type and mutant embryos (data not shown those in zebrafish, suggest that PlexinD1 signaling may
mediate guidance cues responsible for some aspectsand Supplemental Figure S1).
of vascular patterning.
Coronary and Intersomitic Blood Vessel Defects
in plexinD1/ Mice PlexinD1 Associates with Neuropilin to Form
a Receptor for Class 3 SemaphorinsAt E12.5, cardiac development is notably abnormal in
knockout embryos. The atria are enlarged and thin- The cardiac OT defects of plexinD1 knockout mice are
remarkably similar to sema3C knockouts (Feiner etwalled (Figures 3L and 3M). The OT of wild-type embryos
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to Npn-1 is enhanced in the presence of PlexinA1 (Taka-
hashi et al., 1999). However, no plexin previously has
been described to enhance binding of Sema3C to neu-
ropilins. Our data indicate that binding of both Sema3A
and Sema3C to COS cells expressing Npn-1 is greatly
enhanced by cotransfection of PlexinD1 (Figures 5B–
5D). PlexinD1 also enhanced binding of Sema3C to
Npn-2 (Figure 5E). Thus, we propose that PlexinD1 het-
erodimerizes with Npn-1 or Npn-2 to form a receptor
capable of binding SEMA3 proteins.
A Model for the Integration of VEGF
and Semaphorin Signaling
in Cardiovascular Development
The closely related phenotypes involving OT and aortic
arch defects of sema3C, plexinD1, and Npn-1 knockout
mice (summarized in Table 2), coupled with our bio-
chemical data, strongly suggest that semaphorin sig-
naling mediated by ECs expressing PlexinD1 and neu-
ropilins composes a receptor-ligand paracrine signaling
pathway that orchestrates septation of the OT and de-
velopment of aortic arch artery derivatives. Congenital
heart defects in humans frequently involve OT and aortic
arch defects, and SEMA3C, PLEXIND1, and NPN-1 are
candidate genes for congenital heart disease. The ability
of neuropilin to bind distinct ligands (VEGF165 and SEMA3
proteins), coupled with recent elegant genetic studies
(Feiner et al., 2001; Gu et al., 2003; Soker et al., 1998;
Stalmans et al., 2003), has previously suggested that
neuropilin facilitates VEGF signaling in endothelium and
semaphorin signaling in non-ECs including cardiac neu-Figure 5. PlexinD1 Interacts with Npn-1, and This Association En-
ral crest (Gu et al., 2003). Endothelial-specific loss ofhances Binding to Sema3C
Npn-1 has been interpreted in terms of loss of VEGF165(A) Coimmunoprecipitation experiments show that full-length Plex-
signaling in endothelium (Gu et al., 2003). However, ourinD1 (PlexinD1-V5) and a cytoplasmic domain truncation (PlexinD1-
biochemical and genetic data identify a direct role forcyt-V5) can form a complex with Npn-1 and that this interaction
requires the sema domain (PlexinD1sema-V5). neuropilin-mediated semaphorin signaling in endothe-
(B–D) AP-Sema3C binding to Cos-7 cells transfected with Npn-1 lium. This result demands reinterpretation of existing
alone (B), Npn-1 and PlexinA1 (C), or Npn-1 and PlexinD1 (D) was data concerning the role of neuropilin, VEGF, and sema-
measured colorimetrically. Weak binding of Sema3C to Npn-1 or to
phorin signaling in cardiovascular development andNpn-1/PlexinA1 was detected after 20 min incubation in alkaline
leads us to propose a unifying model (Figure 6). Wephosphatase staining solution (B and C), whereas strong binding
suggest that neuropilin, in ECs, functions in both VEGFwas detected to Npn-1/PlexinD1 transfected cells (D).
(E) Summary of AP-Sema binding experiments. Shown is one of five and semaphorin signaling and that both pathways are
experiments with similar results. Data are displayed as mean pixel required for proper cardiac OT development. Either
intensity (arbitrary units) after subtraction of background (mean  Npn-1 or Npn-2 is able to cooperate with PlexinD1 to
SEM, n  5). *p 	 0.01, **p 	 0.05. bind Sema3C. This explains why specific inhibition of
Npn-1-dependent semaphorin signaling does not result
in OT defects unless the redundant Npn-2 is also inacti-
al., 2001), endothelial-restricted neuropilin-1 (Npn-1) vated (Gu et al., 2003), whereas inactivating either the
knockouts (Gu et al., 2003), and Npn-1[-sema];Npn-2 knock- ligand Sema3C (Feiner et al., 2001) or the coreceptor
outs (Gu et al., 2003). Furthermore, plexinD1, Npn-1, and PlexinD1 is sufficient to produce OT defects.
Npn-2 are coexpressed in endothelium and sema3C is This model also explains why loss of the VEGF signal-
expressed by outflow tract myocardium (Figures 2H– ing component, by virtue of either an isoform specific
2K). Therefore, we sought to determine if PlexinD1 could VEGF165 knockout (Stalmans et al., 2003) or endothelial
heterodimerize with Npn-1 to form a functional receptor restricted Npn-1 knockout (Gu et al., 2003) leads to OT
for Sema3C. Coimmunoprecipitation experiments indi- defects. Finally, our model explains defects in atrial de-
cate that PlexinD1 and Npn-1 can associate, and this velopment associated with disruptions in semaphorin
interaction requires the sema domain of PlexinD1 (Figure signaling in ECs. We propose that Sema3A provides this
5A). Different SEMA3 proteins bind to Npn-1 or Npn-2 signal to PlexinD1 and Npn-1. Accordingly, sema3A,
with varying affinities. Sema3A binds to Npn-1 but not endothelial-restricted Npn-1, and plexinD1 knockout
Npn-2, while Sema3C can bind to both neuropilins (Chen mice present with similar atrial defects (Behar et al.,
et al., 1997; He and Tessier-Lavigne, 1997; Kolodkin et 1996; Gu et al., 2003), although these studies do not
al., 1997; Takahashi et al., 1998). Plexins can enhance address the question of whether atrial defects are pri-
the binding of SEMA3 proteins to neuropilins (He and mary or secondary to distinct cardiovascular abnormali-
Tessier-Lavigne, 1997; Kolodkin et al., 1997; Takahashi ties. Additional SEMA3 genes are expressed during car-
diac development in regionalized patterns (A.D.G. andet al., 1999; Tamagnone et al., 1999). Sema3A binding
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Table 2. Cardiac Phenotypes in Semaphorin and VEGF Signaling Mutants
Genotype PTA VSD Cardiac Phenotypes Reference
Coronary Artery Aortic Arch
Anomaly Defects Atrial Defects
PlexinD1/    a 
Sema3C/    b  Feiner et al., 2001
Sema3A/      Behar et al., 1996
Npn1ecKO      Gu et al., 2003
Npn1[Sema-]      Gu et al., 2003
Npn1[Sema-];Npn2/      Gu et al., 2003
VEGF165/    c  Stalmans et al., 2003
Comparison of frequency of specific cardiac embryonic phenotypes between Semaphorin and VEGF signaling pathway mutants. Endothelial-
restricted Neuropilin-1 knockout (Npn1ecKO); persistent truncus arteriosus (PTA); ventricular septal defect (VSD). a, subset of mutants have
right-sided aortic arch. b, interrupted aortic arch. c, mutants can present with either right-sided arch or interrupted aortic arch. (“” indicates
not present or not reported).
J.A.E., unpublished data). It is likely that PlexinD1 and vascular development and angiogenesis via autocrine
signals in ECs, resulting in alterations in integrin activa-neuropilin function together in ECs to transduce multiple
semaphorin signals required for various aspects of car- tion and adhesiveness to extracellular matrix (Serini et
al., 2003). Interestingly, SEMA3C expression was notdiovascular development.
In zebrafish, PlexinD1 functions to mediate repulsive detected in vitro in human ECs (Serini et al., 2003). This
is consistent with our data, which suggest sema3C, ex-signals during sprouting and growth of the intersomitic
vessels (Torres-Vazquez et al., 2004) while cardiac mor- pressed by OT myocardium, is involved in paracrine
signaling to ECs expressing the receptors Npn-1, Npn-2,phogenesis appears normal. However, fish do not have
a septated outflow tract. The observation of vascular and PlexinD1. Taken together, these results demon-
strate unexpected similarities between neural pattern-and cardiac outflow tract defects in mice lacking
PlexinD1 suggests that this endothelial receptor has ing, vascular patterning, and endothelial function during
cardiovascular morphogenesis.acquired new functions during evolution coincident with
increased complexity of cardiovascular patterning. Re-
Experimental Procedurescent data indicate that SEMA3 proteins play a role in
In Situ Hybridization
Whole-mount and in situ hybridization protocols are available at
http://www.uphs.upenn.edu/mcrc/histology/histologyhome.html.
The plexinD1 antisense riboprobe derived from EST #AA138454 cor-
responding to bp 5901–6955 of mouse plexinD1 mRNA (Accession
# XM_149784). 35S-labeled antisense riboprobes were synthesized
by in vitro run-off transcription of linearized plasmids, using SP6,
T7 or T3 RNA polymerase, and 35S-UTP. Probes for FoxC1 (Kume
et al., 2001), ednrA (Yanagisawa et al., 1998), plexinA2 (Brown et
al., 2001), Npn-1 (Brown et al., 2001), Npn-2 (Brown et al., 2001),
and ET-1 (Yanagisawa et al., 1998) have been described previously.
The sema3C probe was prepared from a 3.2 kb mouse cDNA cloned
into pBSII/KS (provided by Jonathan Raper). The plasmid was linear-
ized with Not 1 and transcribed with T3 RNA polymerase. The
PDGF-b and PDGFR- probes derived from EST #BE554525 and
#BF120498, respectively, by linearization with EcoR1 and transcrip-
tion with T7 RNA polymerase. The EphrinB2 and LKLF templates
were kindly provided by John Lee and Mark Kahn, and we used T7
polymerase to synthesize antisense riboprobes.
Immunohistochemistry
Immunohistochemistry protocols are available at http://www.uphs.
upenn.edu/mcrc/histology/histologyhome.html. To detect PlexinD1
protein, we used rabbit polyclonal antisera raised against a 60 amino
acid peptide (corresponding to aa 186–237) of mouse PlexinD1 (Ac-
cession # XP_149784) at a dilution of 1:500. To detect PECAM, we
used CD31 antiserum at a dilution of 1:500. To detect  smooth
muscle actin, we used A2547 (Sigma) at a dilution of 1:1000. To
Figure 6. A Model for the Integration of VEGF and Semaphorin Sig- detect vWF, we used Von Willebrand Factor antiserum (Sigma) at
naling in Cardiovascular Development a dilution of 1:20 with the Zenon labeling kit (Molecular Probes). To
detect neurofilament, we used monoclonal antibody 2H3 (Develop-Endothelial cells express neuropilin receptors capable of heterodi-
mental Studies Hybridoma Bank) at a dilution of 1:10.merization with PlexinD1 or the VEGF receptor KDR. Both VEGF
signaling (mediated by VEGF165 and KDR) and semaphorin signaling
(mediated by Sema3C and PlexinD1) utilize neuropilin receptor com- Northern Blotting
Total RNA was isolated from endothelial cell lines using Trizol (In-plexes and are required for outflow tract development. Disruptions
in Sema3A-dependent semaphorin signaling cause atrial defects. vitrogen). 20 
g of total RNA was used for Northern blots hybridized
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with a 32P-labeled probe generated from EST #AA138454, cor- M. (1997). Neuropilin-2, a novel member of the neuropilin family, is
a high affinity receptor for the semaphorins Sema E and Sema IVresponding to bp 5901–6955 of mouse plexinD1 (Accession
# XP_149784). but not Sema III. Neuron 19, 547–559.
Creazzo, T.L., Godt, R.E., Leatherbury, L., Conway, S.J., and Kirby,
Generating plexinD1 Knockout Mice M.L. (1998). Role of cardiac neural crest cells in cardiovascular
We constructed a targeting vector based on pPNT-loxP (Tybulewicz development. Annu. Rev. Physiol. 60, 267–286.
et al., 1991). PCR was used to amplify 6 kb and 2 kb long and short
Feiner, L., Webber, A.L., Brown, C.B., Lu, M.M., Jia, L., Feinstein,
homology arms from R1 ES cell genomic DNA. We screened 600
P., Mombaerts, P., Epstein, J.A., and Raper, J.A. (2001). Targeted
drug-resistant R1 ES clones by Southern blotting and identified five
disruption of semaphorin 3C leads to persistent truncus arteriosus
correctly targeted clones. Two clones were injected into C57Bl/6
and aortic arch interruption. Development 128, 3061–3070.
blastocysts to generate chimeric mice that were crossed to C57Bl/6
Goodman, C.S., Kolodkin, A.L., Luo, Y., Puschel, A.W., and Raper,to generate heterozygous plexinD1 knockout mice. (Primer se-
J.A. (1999). Unified nomenclature for the semaphorins/collapsins.quences for PCR genotyping are available upon request.)
Semaphorin Nomenclature Committee. Cell 97, 551–552.
Coimmunoprecipitation Gu, C., Rodriguez, E.R., Reimert, D.V., Shu, T., Fritzsch, B., Richards,
We transfected 1 106 HEK293T cells with 5
g myc-Npn-1 and 5
g L.J., Kolodkin, A.L., and Ginty, D.D. (2003). Neuropilin-1 conveys
of pcDNA3.1, pcDNA3.1-plexinD1-V5, pcDNA3.1-plexinD1Cyt-V5, semaphorin and VEGF signaling during neural and cardiovascular
pcDNA3.1-plexinD1Sema-V5, or pcDNA3.1-plexinA2Cyt-V5. These development. Dev. Cell 5, 45–57.
constructs were derived from cDNA KIAA0620 (Accession # AB014520). Hall, K.T., Boumsell, L., Schultze, J.L., Boussiotis, V.A., Dorfman,
48 hr after transfection, cells were lysed in NP-40 lysis buffer (150 D.M., Cardoso, A.A., Bensussan, A., Nadler, L.M., and Freeman, G.J.
mM NaCl, 50 mM Tris [pH 8.0], 1% NP-40) and immunoprecipitated (1996). Human CD100, a novel leukocyte semaphorin that promotes
with a monoclonal V5 antibody (Invitrogen) for 2 hr at 4C. Complexes B-cell aggregation and differentiation. Proc. Natl. Acad. Sci. USA
were incubated with protein A/G sepharose (Santa Cruz), separated 93, 11780–11785.
by SDS-PAGE and transferred to PVDF membranes. We used a
He, Z., and Tessier-Lavigne, M. (1997). Neuropilin is a receptor for
monoclonal myc antibody (9E10) to detect Npn-1 by Western
the axonal chemorepellent Semaphorin III. Cell 90, 739–751.
blotting.
Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., and Betsholtz,
C. (1999). Role of PDGF-B and PDGFR-beta in recruitment of vascu-AP-Sema Binding Experiments
lar smooth muscle cells and pericytes during embryonic blood ves-HEK293T cells were transfected with pAG-AP-Sema3C. 48 hr after
sel formation in the mouse. Development 126, 3047–3055.transfection, conditioned medium was diluted 1:10 in DMEM with
10% FBS. Separately, we transfected 2  105 COS-7 cells with 0.4 Holmes, S., Downs, A.M., Fosberry, A., Hayes, P.D., Michalovich,

g Npn-1 and 2 
g pcDNA3.1, PlexinA1, or PlexinD1. Transfected D., Murdoch, P., Moores, K., Fox, J., Deen, K., Pettman, G., et al.
COS-7 cells were incubated with diluted AP-Sema3C conditioned (2002). Sema7A is a potent monocyte stimulator. Scand. J. Immunol.
media for 90 min at room temperature, washed with PBS, and fixed 56, 270–275.
with 4% paraformaldehyde. Endogenous alkaline phosphatases Ito, T., Kagoshima, M., Sasaki, Y., Li, C., Udaka, N., Kitsukawa, T.,
were inactivated by heating at 65C for 3 hr. AP-Sema binding was Fujisawa, H., Taniguchi, M., Yagi, T., Kitamura, H., and Goshima, Y.
detected by incubating cells in AP buffer (100 mM Tris [pH 9.5], (2000). Repulsive axon guidance molecule Sema3A inhibits
100 mM NaCl, 50 mM MgCl2–0.1% Tween 20, 0.33 mg/ml nitroblue branching morphogenesis of fetal mouse lung. Mech. Dev. 97,
tetrazolium, and 0.05 mg/ml BCIP) for 20–30 min at room tempera- 35–45.
ture. Stained cells were digitally photographed and staining intensity
Kirby, M.L., Gale, T.F., and Stewart, D.E. (1983). Neural crest cellswas quantified using ImageJ software (NIH).
contribute to normal aorticopulmonary septation. Science 220,
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